Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RIVERO, Antonio")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 69

  • Page / 3
Export

Selection :

  • and

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitorsRIVERO, Antonio; MIRA, José A; PINEDA, Juan A et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 3, pp 342-346, issn 0305-7453, 5 p.Article

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/ Hepatitis C Virus―Coinfected Patients With Compensated CirrhosisMIRA, José A; RIVERO-JUAREZ, Antonio; GEA, Isabel et al.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1646-1653, issn 1058-4838, 8 p.Article

Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in SpainMERCHANTE, Nicolás; MERINO, Esperanza; PADILLA, Sergio et al.Clinical infectious diseases. 2013, Vol 56, Num 1, pp 143-150, issn 1058-4838, 8 p.Article

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patientsMANDORFER, Mattias; NEUKAM, Karin; MEYER-OLSON, Dirk et al.AIDS (London). 2013, Vol 27, Num 17, pp 2707-2714, issn 0269-9370, 8 p.Article

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patientsPINEDA, Juan A; CARUZ, Antonio; DI LELLO, Federico A et al.AIDS (London). 2011, Vol 25, Num 11, pp 1415-1420, issn 0269-9370, 6 p.Article

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations : effect of hepatitis virus co-infection and pre-existing fibrosisMACIAS, Juan; ORIHUELA, Francisco; ABDEL-KADER, Laila et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 1, pp 178-183, issn 0305-7453, 6 p.Article

Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events: A Randomized TrialGUTIERREZ-VALENCIA, Alicia; VICIANA, Pompeyo; PALACIOS, Rosario et al.Annals of internal medicine. 2009, Vol 151, Num 3, pp 149-156, issn 0003-4819, 8 p.Article

Pain in the lower limbs of a patient with AIDSGARCIA-LAZARO, Milagros; CANO, Antonio; VIDAL, Elisa et al.Clinical infectious diseases. 2006, Vol 42, Num 3, issn 1058-4838, 392-393,428-430 [5 p.]Article

Failure of Cetirizine to prevent nevirapine-associated rash: A double-blind placebo-controlled trial for the GESIDA 26/01 studyKNOBEL, Hernando; MIRO, José M; BOIX, Vicente et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 2, pp 1276-1281, issn 1525-4135, 6 p.Article

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialSULKOWSKI, Mark; POL, Stanislas; WENNING, Larissa et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 597-605, issn 1473-3099, 9 p.Article

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infectionNEUKAM, Karin; CARUZ, Antonio; MACIAS, Juan et al.AIDS (London). 2013, Vol 27, Num 17, pp 2715-2724, issn 0269-9370, 10 p.Article

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapyLLIBRE, Josep M; ARRIBAS, Jose R; DOMINGO, Pere et al.AIDS (London). 2011, Vol 25, Num 14, pp 1683-1690, issn 0269-9370, 8 p.Article

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirinMACIAS, Juan; DEL VALLE, José; TORRE-CISNEROS, Julián et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 10, pp 2204-2211, issn 0305-7453, 8 p.Article

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavirVISPO, Eugenia; BARREIRO, Pablo; RIVERO, Antonio et al.Antiviral therapy (London). 2008, Vol 13, Num 3, pp 429-437, issn 1359-6535, 9 p.Article

A case-control study of HIV patients with the K65R mutation in the reverse transcriptase gene with virological failurePALACIOS, Rosario; VICIANA, Isabel; LOPEZ-RUZ, Miguel A et al.AIDS (London). 2005, Vol 19, Num 16, pp 1928-1930, issn 0269-9370, 3 p.Article

High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain BRIVERO, Antonio; MARQUEZ, Manuel; SANTOS, Jesus et al.Clinical infectious diseases. 2001, Vol 32, Num 1, pp 159-161, issn 1058-4838Article

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patientsPINEDA, Juan A; CIFUENTES, Celia; PARRA, Manuel et al.AIDS (London). 2014, Vol 28, Num 13, pp 1931-1937, issn 0269-9370, 7 p.Article

Differences in Virological Response to Peginterferon-α Plus Ribavirin in HIV-Positive Patients Coinfected With HCV Subtypes 1a or 1 bRALLON, Norma I; PINEDA, Juan A; BARREIRO, Pablo et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 2, pp 117-123, issn 1525-4135, 7 p.Article

CD45RA expression on HCMV-specific effector memory CD8+ T cells is associated with the duration and intensity of HCMV replication after transplantationCANTISAN, Sara; SOLANA, Rafael; LARA, Rosario et al.Clinical immunology (Orlando, Fla. Print). 2010, Vol 137, Num 1, pp 81-88, issn 1521-6616, 8 p.Article

Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometryNEUKAM, Karin; RECIO, Eva; CAMACHO, Angela et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 7, pp 801-807, issn 0954-691X, 7 p.Article

Long-Term Assessment of Didanosine, Lamivudine, and Efavirenz in Antiretroviral-Naive Patients : 3-Year Follow-UpSANTOS, Jesus; PALACIOS, Rosario; LOZANO, Fernando et al.AIDS research and human retroviruses. 2008, Vol 24, Num 1, pp 24-26, issn 0889-2229, 3 p.Article

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapyPINEDA, Juan A; GARCIA-GARCIA, José A; CAMACHO, Angela et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 3, pp 622-630, issn 0270-9139, 9 p.Article

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis CMOCIOS, Juan; MIRA, José A; TRASTOY, Monica et al.Antiviral therapy (London). 2006, Vol 11, Num 7, pp 839-846, issn 1359-6535, 8 p.Article

Detection of simultaneous β-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infectionRAZONABLE, Raymund R; RIVERO, Antonio; PAYA, Carlos V et al.Clinical transplantation. 2003, Vol 17, Num 2, pp 114-120, issn 0902-0063, 7 p.Article

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systemsRAZONABLE, Raymund R; BROWN, Robert A; ESPY, Mark J et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 12, pp 4472-4476, issn 0095-1137Article

  • Page / 3